SCHEMBL4419804

SCHEMBL4419804

Cc1ccc(P(=O)(c2ccc(C)cc2)c2ccc(O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.62
LMNA P02545 2/20 0.56
TSHR P16473 2/20 0.56
HPGD P15428 3/20 0.52
GAA P10253 4/20 0.50
ESR1 P03372 3/20 0.50
ALDH1A1 P00352 4/20 0.43
MAPT P10636 5/20 0.41
POLB P06746 3/20 0.41
KDM4E B2RXH2 3/20 0.41
ESR2 Q92731 3/20 0.41
RAB9A P51151 3/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
MEN1 O00255 2/20 0.39
ALOX15 P16050 2/20 0.39
BLM P54132 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5618886 1.00 ACHE (0.62) ACHELMNATSHRHPGDGAA
SCHEMBL28397519 0.92 ESR1 (0.64) ACHELMNATSHRHPGDGAA
SCHEMBL5435185 0.87 HPGD (0.65) ACHELMNATSHRHPGDGAA
SCHEMBL262688 0.87 HPGD (0.65) ACHELMNATSHRHPGDGAA
SCHEMBL811982 0.87 ESR1 (0.54) LMNAHPGDESR1ALDH1A1MAPT
SCHEMBL6626629 0.85 HPGD (0.62) ACHELMNATSHRHPGDGAA
SCHEMBL15681792 0.82 LTA4H (0.53) ACHEHPGDESR1MAPTPOLB
P-Cresol SCHEMBL28453798 0.82 ACHE (0.72) ACHELMNATSHRHPGDGAA
P-Cresol SCHEMBL30339010 0.82 ACHE (0.72) ACHELMNATSHRHPGDGAA
P-Cresol SCHEMBL30644866 0.82 ACHE (0.72) ACHELMNATSHRHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4311938-B2 2009-08-12 JP claimed
US-7202311-B2 Phosphine oxide hydroxyarl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CORPORATION (US) 2007-04-10 US claimed
EP-1363922-B1 NOVEL HYDROXYARYL PHOSPHINE OXIDES MIXTURE, GLYCIDYL ETHERS AND EPOXY COMPOSITIONS, COMPOSITES AND LAMINATES DERIVED THEREFROM GREAT LAKES CHEMICAL CORP (US) 2006-07-26 EP claimed
US-20040225080-A1 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CHEMICAL CORPORATION 2004-11-11 US claimed
JP-2004533413-A 2004-11-04 JP claimed
US-20040121990-A1 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom GREAT LAKES CHEMICAL CORPORATION 2004-06-24 US claimed
US-6733698-B2 Mixture of mono-, bis- and tris-(hydroxyaryl) phosphine oxides useful to make polyglycidyl ethers or in epoxy compositions PABU SERVICES, INC. 2004-05-11 US claimed
EP-1363922-A2 NOVEL HYDROXYARYL PHOSPHINE OXIDES, GLYCIDYL ETHERS AND EPOXY COMPOSITIONS, COMPOSITES AND LAMINATES DERIVED THEREFROM Pabu Services, Inc. (US) 2003-11-26 EP claimed
US-20030148109-A1 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins CHEMTURA CORPORATION 2003-08-07 US claimed
US-20020168527-A1 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom GREAT LAKES CHEMICAL CORPORATION 2002-11-14 US claimed
WO-2002066485-A2 NOVEL HYDROXYARYL PHOSPHINE OXIDES, GLYCIDYL ETHERS AND EPOXY COMPOSITIONS, COMPOSITES AND LAMINATES DERIVED THEREFROM PABU SERVICES, INC. (US) 2002-08-29 WO claimed
US-7201957-B2 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CORPORATION (US) 2007-04-10 US disclosed
US-7202311-B2 Phosphine oxide hydroxyarl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CORPORATION (US) 2007-04-10 US disclosed
EP-1363922-B1 NOVEL HYDROXYARYL PHOSPHINE OXIDES MIXTURE, GLYCIDYL ETHERS AND EPOXY COMPOSITIONS, COMPOSITES AND LAMINATES DERIVED THEREFROM GREAT LAKES CHEMICAL CORP (US) 2006-07-26 EP disclosed
US-6887950-B2 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins PABU SERVICES, INC. (US) 2005-05-03 US disclosed
US-20050020801-A1 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CHEMICAL CORPORATION 2005-01-27 US disclosed
US-20040225080-A1 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins GREAT LAKES CHEMICAL CORPORATION 2004-11-11 US disclosed
US-20030148109-A1 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins CHEMTURA CORPORATION 2003-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040121990-A1 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom PFAS, PTPMT1, PWWP2B ACHE 1440/4885LMNA 724/4885TSHR 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.